CRIS Current Research Information System

LOGGI, ELISABETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.236
AS - Asia 2.106
EU - Europa 1.954
AF - Africa 164
SA - Sud America 130
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.210
SG - Singapore 737
CN - Cina 622
GB - Regno Unito 524
SE - Svezia 350
VN - Vietnam 284
DE - Germania 260
IT - Italia 223
HK - Hong Kong 188
IN - India 115
UA - Ucraina 101
BR - Brasile 95
IE - Irlanda 86
RU - Federazione Russa 86
FR - Francia 81
NL - Olanda 59
TG - Togo 51
KR - Corea 49
ZA - Sudafrica 45
BE - Belgio 40
EE - Estonia 34
JP - Giappone 33
JO - Giordania 32
CI - Costa d'Avorio 31
FI - Finlandia 29
CH - Svizzera 21
SC - Seychelles 21
CA - Canada 17
AR - Argentina 16
GR - Grecia 15
BG - Bulgaria 13
IR - Iran 13
EC - Ecuador 7
MX - Messico 7
PL - Polonia 7
AT - Austria 6
BD - Bangladesh 6
ES - Italia 6
NG - Nigeria 6
LB - Libano 5
TR - Turchia 5
CL - Cile 4
ID - Indonesia 4
RO - Romania 4
DK - Danimarca 3
MY - Malesia 3
PK - Pakistan 3
IQ - Iraq 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SN - Senegal 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
CO - Colombia 1
DM - Dominica 1
DZ - Algeria 1
EG - Egitto 1
GN - Guinea 1
GT - Guatemala 1
IL - Israele 1
KE - Kenya 1
LT - Lituania 1
LU - Lussemburgo 1
ML - Mali 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
TW - Taiwan 1
TZ - Tanzania 1
UY - Uruguay 1
YT - Mayotte 1
Totale 7.592
Salva come PNG Salva come JPEG
Città #
Singapore 528
Southend 459
Fairfield 366
Chandler 341
Ashburn 332
Hong Kong 185
Woodbridge 180
Ann Arbor 175
Dong Ket 158
Houston 154
Seattle 150
Wilmington 148
Santa Clara 145
Cambridge 134
Hefei 132
Princeton 111
Dublin 86
Beijing 85
Boardman 72
Jacksonville 63
Lomé 51
Dallas 49
Nanjing 49
Seoul 47
Westminster 47
Padova 44
Brussels 39
Ho Chi Minh City 39
Hanoi 33
Los Angeles 33
Amman 32
Bologna 32
Jinan 32
Tokyo 32
Abidjan 31
Berlin 26
Buffalo 26
San Diego 24
Changsha 22
Shenyang 22
Turin 22
Munich 19
Frankfurt am Main 18
Milan 18
Redondo Beach 18
Hebei 17
Helsinki 16
Nanchang 16
São Paulo 16
Bern 15
Bremen 15
Saint Petersburg 15
Bengaluru 13
Mülheim 13
New York 13
Rome 12
Sofia 12
Mahé 11
Zhengzhou 11
Florence 10
Tianjin 10
Toronto 10
Turku 10
Amsterdam 9
Des Moines 9
Guangzhou 9
Ningbo 9
Redmond 9
San Francisco 9
Dearborn 8
Kunming 8
Taizhou 8
Yubileyny 8
Dolo 7
Falkenstein 7
London 7
Washington 7
Abeokuta 6
Da Nang 6
Haikou 6
Jiaxing 6
Lanzhou 6
Medford 6
Paris 6
Phoenix 6
Redwood City 6
Zola Predosa 6
Chicago 5
Falls Church 5
Frankfurt Am Main 5
Norwalk 5
San Venanzo 5
Shanghai 5
Vienna 5
Andover 4
Brooklyn 4
Foshan 4
Haiphong 4
Hangzhou 4
Hải Dương 4
Totale 5.277
Salva come PNG Salva come JPEG
Nome #
Adaptive response in Hepatitis B virus infection 232
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection. 213
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study. 202
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 191
Alcoholic liver disease: pathophisiological aspects and risk factors. A review. 181
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 179
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen. 178
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 173
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 172
Vitamins in the treatment of chronic viral hepatitis. 167
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma. 166
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. 162
Chronic hepatitis B: Are we close to a cure? 162
Vitamin E for the treatment of children with hepatitis B e antigen-positive chronic hepatitis: A systematic review and meta-analysis 159
Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B 157
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients. 156
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 155
Simultaneous assessment of cytotoxic T lymphocyte responses against multiple viral infections by combined usage of optimal epitope matrices, anti- CD3 mAb T-cell expansion and "RecycleSpot" 154
Hepatitis B virus and immune response. 153
Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies 152
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 152
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. 148
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B. 148
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 147
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 147
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 145
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 145
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. 143
Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with liver cirrhosis 140
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C. 139
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 139
Liver grafts from hepatitis B surface antigen-positive donors: A review of the literature 135
Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV. 134
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. 132
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis. 131
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C. 130
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study. 128
Development of psychiatric symptoms during antiviral therapy for chronic hepatitis C: a retrospective study on 590 subjects. 124
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 122
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS). 120
SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses 113
Host ethnicity and genotype shape the hepatitis B virus-specific T-cell repertoire 110
Uno studio retrospettivo su 590 soggetti: sintomi psichiatrici durante la terapia antivirale per l’epatite cronica C. 107
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis. 106
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 105
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 104
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection 104
null 98
Proteomics of immune cells from liver tumors reveals immunotherapy targets 97
null 92
Virological Treatment Monitoring for Chronic Hepatitis B 90
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection. 89
METABOLIC EFFECTS OF ANTI-HCV DIRECT ACTING ANTIVIRALS (DAA): A RETROSPECTIVE STUDY 88
Infections and organ transplantation: new challenges for prevention and treatment--a colloquium. 86
SPONTANEOUS MOBILIZATIONOF BONE MARROW-DERIVED HEMATOPOIETIC AND ENDOTHELAIL PROGENITOR CELLS AFTER ORTHOTOPIC LIVER TRANSPALNTATION (OLT). 80
Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome 8
Totale 7.690
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.553
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.553
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021435 0 0 0 0 0 27 17 51 55 32 41 212
2021/20221.108 76 32 93 118 83 58 18 61 46 107 229 187
2022/20231.165 140 204 65 164 62 99 28 47 192 32 84 48
2023/2024257 17 55 21 34 24 32 11 29 5 15 3 11
2024/20251.135 32 182 63 104 198 47 55 22 25 69 38 300
2025/20261.393 211 248 274 222 368 70 0 0 0 0 0 0
Totale 7.690